Analysis of cardiovascular and arteriothrombotic adverse events in chronic-phase CML patients after frontline TKIs.
暂无分享，去创建一个
Z. Estrov | H. Kantarjian | G. Garcia-Manero | J. Cortes | S. Verstovsek | T. Kadia | P. Jain | F. Ravandi | G. Borthakur | E. Jabbour | S. O'brien | G. Nogueras-Gonzalez | K. Sasaki | P. Boddu | H. Ahaneku | P. Sam